Skip to content
| SUBSCRIBE | MEMBERS AREA | JOBS

We are exposed to chemicals everywhere in our daily lives. This exposure has been associated with numerous health impacts, such as cancer, weakening of the immune system, and normal functioning of organs, disruption of the hormonal system and the reproductive system, birth defects, and negative impacts on the mental, intellectual, and physical development of children.

HEAL works with partners and decision-makers to minimise and ultimately end human exposure to hazardous and health-harming chemicals in Europe, and towards protective laws and regulations for a non-toxic environment.

Chemicals agency’s socio-economic committee finalises PFAS assessment – now the EU needs a robust PFAS restriction

HEAL calls on the European Commission to swiftly deliver a draft proposal for a broad restriction of PFAS.

Read more

Press note: Health groups call for a robust EU PFAS restriction following Court of Auditors’ report

The European Court of Auditors confirms that the time for half-measures has passed, and the EU has to lead with comprehensive, coordinated action that matches the scale and urgency of the PFAS crisis. Phasing out PFAS across the EU is urgent to prevent diseases, as the forever chemicals have been linked to severe health impacts including cancer, liver damage, high blood pressure, immune system dysfunction, reproductive health and others.

Read more

UNEP/WHO State of the Science report: evidence on health risks from EDC exposure confirms need for decisive regulatory action

Policy and regulatory measures therefore have to be implemented and reinforced where necessary to promote safer alternatives and reduce health risks. 

Read more

Protecting human health and the environment from endocrine disrupting chemicals

EDCs interfere with the hormone systems of humans and wildlife and are associated with serious health effects, including reproductive disorders, developmental problems, diabetes, obesity, and hormone-related cancers.

Read more

Driving action on REACH restrictions for EDCs under the Restrictions Roadmap

Together with the European Environmental Bureau (EEB), HEAL has written to the Competent Authorities on…

Read more

HEAL Poland training on PFAS with Ministry of Climate and Environment

Over 80 staff of the Polish Ministry of Climate and Environment recently participated in a…

Read more

Press note: Health groups call for a robust EU PFAS restriction following Court of Auditors’ report

The European Court of Auditors confirms that the time for half-measures has passed, and the EU has to lead with comprehensive, coordinated action that matches the scale and urgency of the PFAS crisis. Phasing out PFAS across the EU is urgent to prevent diseases, as the forever chemicals have been linked to severe health impacts including cancer, liver damage, high blood pressure, immune system dysfunction, reproductive health and others.

Read more

HEAL comment on comitology on the REACH chemicals legislation

European Commissioner Roswall has confirmed that the Commission is no longer planning to revise REACH within its current mandate, but looking into the comitology process.

Read more

Omnibus VI: geplante Vereinfachung der EU-Kosmetikverordnung gefährdet Gesundheitsschutz vor krebserregenden Stoffen

Mit dem Ziel der Vereinfachung von EU-Gesetzgebung hat die Europäische Kommission im „Chemikalien- Omnibus" Änderungen an der EU-Kosmetikverordnung vorgeschlagen. Diese würden zu einer bedeutenden Absenkung des Gesundheitsschutzes gegenüber Chemikalien führen, welche Krebs verursachen, die Fortpflanzungsfähigkeit beeinträchtigen und das Erbgut schädigen. Die EU-Kosmetikverordnung regelt die Verwendung von Substanzen für eine breite Palette alltäglicher Körperpflegeprodukte wie Seife, Make-up, Zahnpasta, Cremes und Sonnenschutzmittel.

Read more

HEAL comments to 58th CARACAL meeting: reproductive toxicity and notifications of new hazards

HEAL, together with ChemTrust and ClientEarth, has submitted comments on two topics discussed in the recent 58th CARACAL meeting.

Read more

Options for improved implementation, enforcement, and modernisation of REACH – civil society recommendations

Read more

HEAL supports the harmonised classification of chloroethane and texanolisobutyrate

HEAL has submitted comments to the proposals for harmonised classification of chloroethane and texanolisobutyrate (TXIB) as reproductive toxicants and endocrine disruptors.

Read more

HEAL comments on the SEAC draft opinion on the proposed restriction of per- and polyfluoroalkyl substances (PFAS)

HEAL supports SEAC (ECHA Committee for Socio-economic Analysis) draft findings that the proposed restriction on PFAS is the most appropriate measure to address the known risks but cautions the any derogations from the restriction must be time-limited and their need thoroughly justified.

Read more

Infographic: The EU must protect people’s health and the environment against endocrine disrupting chemicals (EDCs)

The EDC-Free Europe coalition, of which HEAL is a member, has launched a new infographic illustrating the harmful impacts of exposure to known and suspected endocrine disruptors on our health and the environment. 

Read more

Webinar: Pesticides and Parkinson’s disease: the health impacts of regulatory decisions

Watch the recording of the Health and Environment Alliance (HEAL) and the Dutch Parkinson's Association (De Parkinson Vereniging) for our upcoming science and policy webinar, “Pesticides and Parkinson's disease: the health impacts of regulatory decisions”

Read more

Plastic, Chemicals & Infertility: What we know now

In this EDC Strategies Partnership webinar, Dr. Swan discussed the science behind the "Plastic Detox" movie, details of the “detox” process the participating couples undertook, and how to understand the implications of this experiment.

Read more

Webinar: Addressing Chemical Mixtures: Opportunities for the REACH revision

Dr. Christina Rudén explained why assessing the risk of individual chemicals is not sufficient to protect health.. She explained the need to add a “Mixture Assessment Factor” which adjusts the acceptable exposure level for each individual chemical downwards to provide a protective margin for mixture effects. Over 250 scientists have urged the European Commission to address mixtures to address these risks in the forthcoming revision of the European Union’s Registration, Evaluation and Authorization of Chemicals (REACH) regulation. These points are relevant for risk assessment and regulation in the US and other countries as well. 

Read more

Voices of Hope: video series

As we move into 2026, we're drawing inspiration from individuals who create real change through…

Read more
Why REACH needs a mixture assessment factor

Adding a Mixture Assessment Factor to REACH

Adding a Mixture Assessment Factor (MAF) to the REACH legislation is a simple way to…

Read more

Six demands for a health-first reform of REACH

The European Commission has announced an overhaul of REACH, the legislation that regulates harmful chemicals…

Read more

Driving action on REACH restrictions for EDCs under the Restrictions Roadmap

Together with the European Environmental Bureau (EEB), HEAL has written to the Competent Authorities on…

Read more

Joint letter: Advancing chemical safety in the EU through stronger implementation and enforcement of REACH

HEAL and EEB have sent a joint letter to Vice-President Sejourné and Commissioner Roswall.

Read more

Letter to EP ENVI and IMCO: Vote on Omnibus VI (Chemicals and cosmetic products) – serious concerns for health protection

HEAL has sent a letter to members of the European Parliament's ENVI and IMCO committees, regarding their upcoming vote on changes to the provisions of the Cosmetic Products Regulation, via the Chemicals Omnibus, calling for their support to maintain the high level of protection in the EU Cosmetics regulation.

Read more
Back To Top